<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; different</title>
	<atom:link href="http://www.tapanray.in/tag/different/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Biologic Medicine: Ushers in a different &#8216;Mega Race&#8217; for inorganic growth</title>
		<link>http://www.tapanray.in/biologic-medicine-ushers-in-a-different-mega-race-for-inorganic-growth/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biologic-medicine-ushers-in-a-different-mega-race-for-inorganic-growth</link>
		<comments>http://www.tapanray.in/biologic-medicine-ushers-in-a-different-mega-race-for-inorganic-growth/#comments</comments>
		<pubDate>Mon, 02 May 2011 00:30:50 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Biologic]]></category>
		<category><![CDATA[biologicals]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[different]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[inorganic]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[mega]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Race]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Ushers]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=265</guid>
		<description><![CDATA[During the last several years the success of biologics compared to conventional small-molecule drugs to meet the unmet needs of patients, is gradually but surely changing the area of focus of pharmaceutical R&#38;D altogether, making the biotech companies interesting targets &#8230; <a href="http://www.tapanray.in/biologic-medicine-ushers-in-a-different-mega-race-for-inorganic-growth/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/biologic-medicine-ushers-in-a-different-mega-race-for-inorganic-growth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The concept of ‘Value Based Pricing (VBP)’ gaining ground to reduce cost of healthcare and improve access…but India is quite different</title>
		<link>http://www.tapanray.in/the-concept-of-value-based-pricing-vbp-gaining-ground-to-reduce-cost-of-healthcare-and-improve-accessbut-india-is-quite-different/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-concept-of-value-based-pricing-vbp-gaining-ground-to-reduce-cost-of-healthcare-and-improve-accessbut-india-is-quite-different</link>
		<comments>http://www.tapanray.in/the-concept-of-value-based-pricing-vbp-gaining-ground-to-reduce-cost-of-healthcare-and-improve-accessbut-india-is-quite-different/#comments</comments>
		<pubDate>Mon, 13 Dec 2010 01:00:18 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Based]]></category>
		<category><![CDATA[Concept]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[different]]></category>
		<category><![CDATA[gaining]]></category>
		<category><![CDATA[ground]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[HTA]]></category>
		<category><![CDATA[improve]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[patent patented]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[quite]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reduce]]></category>
		<category><![CDATA[reference]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[VBP]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=335</guid>
		<description><![CDATA[So far as the pharmaceutical pricing and increasing access to healthcare are concerned, year 2010 perhaps will be remembered as one of the very significant years, at least, in the recent times. In this year with new healthcare reform, President &#8230; <a href="http://www.tapanray.in/the-concept-of-value-based-pricing-vbp-gaining-ground-to-reduce-cost-of-healthcare-and-improve-accessbut-india-is-quite-different/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-concept-of-value-based-pricing-vbp-gaining-ground-to-reduce-cost-of-healthcare-and-improve-accessbut-india-is-quite-different/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
